A quick, high-yield synthesis of molnupiravir, an investigational COVID antiviral pill (IMAGE)

American Chemical Society

A quick, high-yield synthesis of molnupiravir, an investigational COVID antiviral pill

Caption

A new synthetic route could help ensure an adequate supply of molnupiravir, a promising antiviral drug for COVID-19.

Credit

Copyright © 2009-2021 Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, N.J., U.S.A. All rights reserved.

Usage Restrictions

Contact Merck Sharp & Dohme Corp. if you would like to use the image.

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.